MATTHEW KEATON: Open Payments
NPI 1003244450 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 94 payments from 25 companies in 2025. Trend: 2023 $2,109 · 2024 $1,910 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $408 |
| PFIZER INC. | 9 | $164 |
| ABBVIE INC. | 13 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $154 |
| Lilly USA, LLC | 15 | $143 |
| Novo Nordisk Inc | 6 | $112 |
| Exact Sciences Corporation | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Abbott Laboratories | 3 | $74 |
| Lundbeck LLC | 3 | $63 |
Products named: FARXIGA, NURTEC ODT, CAPLYTA, REXULTI, MOUNJARO, AIRSUPRA, VRAYLAR, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
